Mission
NMD Pharma is dedicated to developing novel treatments to improve muscle function and quality of life of patients with neuromuscular disease.
Vision
A future in which patients with neuromuscular disease live better and more independent lives.
We have a unique translational muscle electrophysiology platform leveraging in-depth know-how of muscle physiology and muscular disorders for discovering and developing first-in-class therapeutics in neuromuscular diseases with a significant unmet medical need.
NMD Pharma is the leading company utilizing ClC-1 Cl- ion channel inhibitors for neuromuscular diseases and currently has one clinical-stage product candidate for the treatment of myasthenia gravis.
We have more than 25 employees with expertise in all areas of drug development. We are headquartered in Aarhus, Denmark, and collaborate with internationally renowned companies and key opinion leaders in the field of neuromuscular diseases.
For more information, please visit the company website.
Company Details
- Employees
- 71
- Founded
- -
- Address
- Palle Juul-Jensens Boulevard 82, Aarhus N,midtjylland 8200,denmark
- Industry
- Biotechnology
- Website
- nmdpharma.com
- HQ
- Aarhus N, Midtjylland
Nmd Pharma A/s Questions
Nmd Pharma A/S's website is nmdpharma.com
Nmd Pharma A/S's LinkedIn profile is https://dk.linkedin.com/company/nmdpharma
Nmd Pharma A/S has
71 employees.
View email and phone details for 71
employees at Nmd Pharma A/S.
Nmd Pharma A/S's industry is
Biotechnology
Nmd Pharma A/S's top competitors are
Adcendo,
Lundbeck,
Minervax Aps,
Immudex,
Teitur Trophics,
Muna Therapeutics,
Draupnir Bio,
Io Biotech,
Hemab Therapeutics,
Acesion Pharma.
Nmd Pharma A/S's categories are Biotechnology
Nmd Pharma A/S's founding year is 2015
